Urology Featured News Apr 23, 2019 Mayo Clinic offers comprehensive care for women with pelvic floor disorders such as pelvic organ prolapse and urinary incontinence Mayo Clinic's unique, multidisciplinary approach to managing sensitive female pelvic floor disorders allows for individualized decision-making and broad access to a multitude of treatment options. Jun 21, 2019 Pushing the envelope of robotic urologic surgery in children A single-port robotic system offers a safe, efficacious approach for minimally invasive surgeries, including pyeloplasty and appendicovesicostomy, in pediatric patients. Jun 21, 2019 New data indicate percutaneous ablation may be an appropriate option for certain patients with renal masses A review of patients treated with partial nephrectomy, percutaneous radiofrequency ablation or percutaneous cryoablation for small renal masses found no clinical or statistical difference in five-year outcomes. Jun 21, 2019 Redefining the male urethral stricture treatment paradigm With Mayo Clinic's outpatient same-day ambulatory surgery approach, 95% of men treated for urethral stricture disease report a high level of patient satisfaction, with no difference in reconstructive outcomes. Latest Videos See All Mayo Clinic expert says heart disease from unnecessarily treating "Low T" serious concern Low T — health risks of testosterone therapy —- Mayo Clinic. William F. Young Jr., M.D. Surgical treatment options for people with prostate cancer Igor Frank, M.D., discusses surgical treatment options for people with prostate cancer. Erectile dysfunction: Harbinger of heart disease? Charanjit S. Rihal, M.D., and Stephen L. Kopecky, M.D., discuss erectile dysfunction and its impact on cardiovascular prognosis and diagnosis. Clinical Trials See All Benign and Malignant Genitourinary Diseases Urology Biospecimen BankScottsdale/Phoenix, Ariz.Use of Tamsulosin to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine SurgeryRochester, Minn.A Study to Assess the Effectiveness and Safety of UGN-102 as a Primary Chemoablation Agent in Patients with Low Grade Non-Muscle-Invasive Bladder Cancer (LG NMIBC) at Intermediate Risk of RecurrenceJacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz. Publications E-NEWSLETTER EDITION See the latest edition plus past issues More News 1 A novel risk score may help urologists determine which patients with kidney stones require urgent intervention 2 Choice of intraoperative irrigation matters for penile implants: Povidone-iodine leads to a ninefold increase in the likelihood of developing an infection 3 Mayo Clinic experience with da Vinci SP single-port robot-assisted radical prostatectomy 4 New studies of renal masses may assist in patient counseling 5 Boyd R. Viers, M.D., specializes in reconstructive genitourinary surgeries Medical Professionals Urology